Intelligence · Clinical Development
Pipeline search results
Programs matching “placebo” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.
Quick answer
Showing 588 pipeline programs matching "placebo" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.
Refine search
Search results
-
Ramelteon or Placebo
Takeda
Sleep Apnea, Obstructive
1 trial -
Reparixin, Placebo - Tablet for oral use
Dompe' Farmaceutici S.p.A.
Acute Respiratory Distress Syndrome
1 trial -
S-606001 matching placebo, S-606001
Shionogi B.V.
Late-onset Pompe disease.
1 trial -
SAGE-718-matching placebo
SUPERNUS PHARMACEUTICALS, INC.
Parkinson Disease
1 trial -
SAR442970, NANOBODY® Placebo
Sanofi-aventis Healthcare Pty Ltd
Ulcerative Colitis
1 trial -
SAR443765 / LUNSEKIMIG, Matched Placebo to Test
Sanofi-aventis Healthcare Pty Ltd
Dermatitis atopic
1 trial -
SAR444656, Matched Placebo
Sanofi-aventis Healthcare Pty Ltd
hidradenitis suppurativa
1 trial -
SPYPBO-101 Placebo to SPY072, SPY072
Spyre Therapeutics
Moderately to Severely Active Rheumatologic Disease
1 trial -
Sibeprenlimab, Sibeprenlimab placebo
Otsuka Beijing Research Institute
Treatment of Sjögren’s disease
1 trial -
TAK-954 Placebo
Takeda
Postoperative Gastrointestinal Dysfunction
1 trial -
TEV-53408, Placebo to match TEV-53408
Lacuna Pharma Pty Ltd
Celiac Disease
1 trial -
Tarperprumig Placebo, Tarperprumig
Alexion Europe SAS
Anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis
1 trial -
The Placebo composition is the same of the IMP except the active ingredient
Fondazione Telethon ETS
Optic Pathway Glioma (OPG)
1 trial -
Tildacerfont/Placebo
SPRUCE BIOSCIENCES, INC.
Congenital Adrenal Hyperplasia
2 trials -
TransCon CNP, Placebo for TransCon CNP
Lacuna Pharma Pty Ltd
Achondroplasia in Children and Adolescents
1 trial -
UBT251 Injection 2.0 mg and UBT251 Injection Placebo
United Therapeutics Europe Ltd
Obesity &Amp; Overweight
1 trial -
UBT251 Injection 2.0 mg and UBT251 Injection Placebo
United Therapeutics Europe Ltd
Type 2 Diabetes Mellitus (T2DM)
1 trial -
VCH-222 or matching placebo
Vertex Pharmaceuticals (Australia) Pty.
Hepatitis C
1 trial -
VDA-1102, VDA-1102 placebo
Lacuna Pharma Pty Ltd
Actinic keratosis
1 trial -
Vialed Saline Placebo, ALXN2030
Alexion Europe SAS
Antibody-Mediated Rejection after Kidney Transplantation
1 trial -
WJMSCs Vs. placebo
The First People's Hospital of Lianyungang
Ischemic Cardiomyopathy
1 trial -
XB2001 or Placebo
XBiotech Germany GmbH
Pancreatic Cancer
1 trial -
ZASOCITINIB, Matching Placebo for TAK-279
Takeda
Hidradenitis Suppurativa
1 trial -
aleniglipron or placebo
Structure Therapeutics
Obesity
1 trial
Frequently asked questions
What is the Clinical Development Intelligence Platform?
It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.
How does this compare to Evaluate Pharma or Citeline?
Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.
Where does pipeline data come from?
Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.
Can I follow a company or program for updates?
Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.